Signal SentrySearchUpdated Nov 20, 05:30 UTCAM Drop
Models · scorecard

Alphagenome 2

What the vendor claims, next to what independent boards measured. The two are never mixed in one column.

At a glance

OpenRouter does not list this model, so there is no price or context window here.

What the vendor claims

Quoted word for word from the vendor's own launch post or model card. Claims, not measurements.

Scores the vendor claims, each with its source and the quoted line
BenchmarkClaimedSource
TenK10K causal variant recallThe source says: AlphaGenome 2 reliably identified nearly twice as many causal variants (30% vs. 16%) and directional gene effects (43% vs. 23%)30%Google DeepMind · Nov 11From Drop #080 · Wed, Nov 11, 2026 · Evening

Independent results

Measured by independent sources (Epoch AI, LMArena, OpenRouter's benchmark runs, τ²-bench, Vectara), not by the vendor. "Listed as" is the source's own name for the model, so you can check our match.

No independent results yet. They appear here as Epoch AI and LMArena add this model.

In the Drops

Models

DeepMind's AlphaGenome 2 predicts DNA variant effects cell type by cell type

Google DeepMind says AlphaGenome 2, trained on more than 100 million cell profiles, found 30% of causal variants on an immune-cell dataset versus 16% for the original. It is open via API for non-commercial research.

Why it matters: Biotech teams can trial it now for research. DeepMind says it is not validated for clinical or diagnostic use, so keep it out of patient decisions.

From Drop #080 · Wed, Nov 11, 2026 · Evening